期刊
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
卷 31, 期 1, 页码 123-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.idc.2016.10.014
关键词
TNF-alpha; Tobacco; TNF blockers; TLR-5; Legionellosis
Legionnaire's disease (LD) is mainly reported in apparently immunocompetent patients. Among them, risk factors include chronic lung disease and smoking. However, LD is also well reported among immunocompromised patients, particularly those treated with anti-tumor necrosis factor alpha therapy, patients with hematological malignancy, and transplant patients. This article discusses the available data on immunity against Legionella spp, epidemiology, clinical presentation, diagnosis, and treatment of LD in immunocompromised patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据